Showing results (351-360 of 1,190) with videos related to

Sort By:
Pageof 119
ACS Applied Materials & Interfaces|March 25, 2022
Site-Specific Displacement-Driven Activation of Supramolecular Photosensitizing Nanoassemblies for Antitumoral Photodynamic TherapyEvelyn Y Xue, Caixia Yang, Wing-Ping Fong, et al.
Postgraduate Medical Journal|October 1, 1991
The practice of rectal examinationD P Ng, J F Mayberry, A S McIntyre, et al.
Chemistry, an Asian Journal|October 21, 2010
Photoinduced electron transfer in a distyryl BODIPY-fullerene dyadJian-Yong Liu, Mohamed E El-Khouly, Shunichi Fukuzumi, et al.
Protein Expression and Purification|September 21, 2010
Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphomaKedar G Patel, Patrick P Ng, Shoshana Levy, et al.
Acta Neurologica Scandinavica|May 11, 2007
Is improvement in impaired cognition and depressive symptoms in post-stroke patients associated with recovery in activities of daily living?S K Saxena, T-P Ng, G Koh, et al.
Gene Therapy|March 5, 2004
Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectorsK L Sargent, P Ng, C Evelegh, et al.
Expert Opinion on Drug Discovery|June 11, 2019
Chikungunya virus drug discovery: still a long way to go?María-Jesús Pérez-Pérez, Leen Delang, Lisa F P Ng, et al.
Journal of Cell Science|December 12, 2001
Beta1PIX, the PAK-interacting exchange factor, requires localization via a coiled-coil region to promote microvillus-like structures and membrane rufflesC G Koh, E Manser, Z S Zhao, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 18, 2001
Intraoperative single-shot "3-in-1" femoral nerve block with ropivacaine 0.25%, ropivacaine 0.5% or bupivacaine 0.25% provides comparable 48-hr analgesia after unilateral total knee replacementH P Ng, K F Cheong, A Lim, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosisA Zisman, C P Ng, A J Pantuck, et al.
Pageof 119